看來載入頁面時發生了錯誤.
我們的團隊已收到通知,但若此問題持續,請透過電郵支援widget工具聯絡我們。
Trend | Peers | Company |
---|---|---|
Is return on equity increasing? | Yes | No |
Is net profit margin increasing? | Yes | No |
Is asset turnover increasing? | No | No |
Is equity multiplier increasing? | Yes | No |
Competitors Used |
---|
The Beauty Health Company |
Waldencast plc |
Unilever PLC |
Colgate-Palmolive Company |
Stemtech Corporation |
Return on Equity Benchmarks | ||||||||
Comparable Companies | ||||||||
SKIN | WALD | UNLY.F | CL | STEK | ELAB | |||
Return On Equity | ||||||||
Latest Twelve Months | -52% | -11% | 30% | 704% | 170% | -130% | ||
Fiscal Year - 1 | -88% | -33% | 35% | 455% | 295% | -228% | ||
Fiscal Year - 2 | 19% | NA | 42% | 353% | 962% | -368% | ||
Fiscal Year - 3 | -278% | NA | 37% | 320% | -43% | NA | ||
Fiscal Year - 4 | 187% | NA | 39% | 627% | -119% | NA | ||
Fiscal Year - 5 | 136% | NA | 46% | NM | NA | NA | ||
Average | -13% | -22% | 38% | 492% | 253% | -242% | ||
Median | -17% | -22% | 38% | 455% | 170% | -228% | ||
Benchmarks | Ticker | |||||||
The Beauty Health Company | NasdaqCM:SKIN | |||||||
Waldencast plc | NasdaqCM:WALD | |||||||
Unilever PLC | OTCPK:UNLY.F | |||||||
Colgate-Palmolive Company | NYSE:CL | |||||||
Stemtech Corporation | OTCPK:STEK |
Financial Performance | ||||||||
Comparable Companies | ||||||||
(in millions) | SKIN | WALD | UNLY.F | CL | STEK | ELAB | ||
Latest Fiscal Year | Dec-24 | Dec-23 | Dec-24 | Dec-24 | Dec-23 | Dec-23 | ||
LTM Period | Dec-24 | Jun-24 | Dec-24 | Dec-24 | Sep-24 | Sep-24 | ||
Revenues | ||||||||
Latest Twelve Months | 334 | 240 | 60,761 | 20,101 | 5 | 2 | ||
Fiscal Year | 334 | 218 | 60,761 | 20,101 | 5 | 2 | ||
Fiscal Year - 1 | 398 | 166 | 59,604 | 19,457 | 5 | 1 | ||
Fiscal Year - 2 | 366 | NA | 60,073 | 17,967 | 4 | 0 | ||
Fiscal Year - 3 | 260 | NA | 52,444 | 17,421 | 4 | NA | ||
Fiscal Year - 4 | 119 | NA | 50,724 | 16,471 | 7 | NA | ||
Fiscal Year - 5 | 167 | NA | 51,980 | 15,693 | NA | NA | ||
Net Income | ||||||||
Latest Twelve Months | (29) | (71) | 5,744 | 2,889 | (5) | (5) | ||
Fiscal Year | (29) | (90) | 5,744 | 2,889 | (5) | (4) | ||
Fiscal Year - 1 | (100) | (96) | 6,487 | 2,300 | (9) | (2) | ||
Fiscal Year - 2 | 44 | (14) | 7,642 | 1,785 | (7) | (1) | ||
Fiscal Year - 3 | (379) | (0) | 6,049 | 2,166 | (1) | (0) | ||
Fiscal Year - 4 | (29) | NA | 5,581 | 2,695 | (3) | NA | ||
Fiscal Year - 5 | (2) | NA | 5,625 | 2,367 | NA | NA | ||
Total Assets | ||||||||
Latest Fiscal Quarter Prior | 929 | 1,087 | 75,266 | 16,393 | 4 | 2 | ||
Latest Fiscal Quarter | 686 | 1,014 | 79,750 | 16,046 | 4 | 11 | ||
Fiscal Year | 686 | 1,043 | 79,750 | 16,046 | 4 | 5 | ||
Fiscal Year - 1 | 929 | 1,090 | 75,266 | 16,393 | 4 | 2 | ||
Fiscal Year - 2 | 1,003 | 347 | 77,821 | 15,731 | 6 | 1 | ||
Fiscal Year - 3 | 1,219 | 0 | 75,095 | 15,040 | 5 | 0 | ||
Fiscal Year - 4 | 223 | NA | 67,659 | 15,920 | 6 | NA | ||
Fiscal Year - 5 | 226 | NA | 64,806 | 15,034 | NA | NA | ||
Fiscal Year - 6 | NA | NA | 61,111 | 12,161 | NA | NA | ||
Common Equity | ||||||||
Latest Fiscal Quarter Prior | 59 | 615 | 18,102 | 609 | (1) | (0) | ||
Latest Fiscal Quarter | 52 | 619 | 19,990 | 212 | (5) | 9 | ||
Fiscal Year | 52 | 625 | 19,990 | 212 | (2) | 4 | ||
Fiscal Year - 1 | 59 | 639 | 18,102 | 609 | (2) | 1 | ||
Fiscal Year - 2 | 167 | (55) | 19,021 | 401 | (3) | 0 | ||
Fiscal Year - 3 | 302 | (0) | 17,107 | 609 | 2 | (0) | ||
Fiscal Year - 4 | (30) | NA | 15,266 | 743 | 2 | NA | ||
Fiscal Year - 5 | (1) | NA | 13,192 | 117 | NA | NA | ||
Fiscal Year - 6 | NA | NA | 11,397 | (102) | NA | NA |